Simulations Plus/$SLP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Simulations Plus
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
Ticker
$SLP
Sector
Health
Primary listing
Employees
245
Headquarters
Website
Simulations Plus Metrics
BasicAdvanced
$283M
-
-$3.15
0.83
-
Price and volume
Market cap
$283M
Beta
0.83
52-week high
$37.67
52-week low
$12.39
Average daily volume
886K
Financial strength
Current ratio
5.111
Quick ratio
4.682
Long term debt to equity
0.364
Total debt to equity
0.581
Profitability
EBITDA (TTM)
13.11
Gross margin (TTM)
53.75%
Net profit margin (TTM)
-78.62%
Operating margin (TTM)
9.06%
Effective tax rate (TTM)
8.95%
Revenue per employee (TTM)
$330,000
Management effectiveness
Return on assets (TTM)
2.74%
Return on equity (TTM)
-41.49%
Valuation
Price to revenue (TTM)
3.512
Price to book
2.28
Price to tangible book (TTM)
5.64
Price to free cash flow (TTM)
26.762
Free cash flow yield (TTM)
3.74%
Free cash flow per share (TTM)
0.525
Growth
Revenue change (TTM)
20.01%
Earnings per share change (TTM)
-757.93%
3-year revenue growth (CAGR)
15.62%
10-year revenue growth (CAGR)
17.09%
3-year earnings per share growth (CAGR)
76.85%
10-year earnings per share growth (CAGR)
31.01%
3-year dividend per share growth (CAGR)
-37.00%
10-year dividend per share growth (CAGR)
-11.34%
What the Analysts think about Simulations Plus
Analyst ratings (Buy, Hold, Sell) for Simulations Plus stock.
Simulations Plus Financial Performance
Revenues and expenses
Simulations Plus Earnings Performance
Company profitability
Simulations Plus News
AllArticlesVideos
SLP Investors Have Opportunity to Join Simulations Plus, Inc. Fraud Investigation with the Schall Law Firm
Business Wire·1 week ago
Simulations Plus and the Institute of Medical Biology of the Polish Academy of Sciences Partnership Announces Results in Validation of ADMET Predictor® Models with Enhanced AI Drug Design
Business Wire·1 week ago
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation – SLP
Business Wire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Simulations Plus stock?
Simulations Plus (SLP) has a market cap of $283M as of August 08, 2025.
What is the P/E ratio for Simulations Plus stock?
The price to earnings (P/E) ratio for Simulations Plus (SLP) stock is 0 as of August 08, 2025.
Does Simulations Plus stock pay dividends?
No, Simulations Plus (SLP) stock does not pay dividends to its shareholders as of August 08, 2025.
When is the next Simulations Plus dividend payment date?
Simulations Plus (SLP) stock does not pay dividends to its shareholders.
What is the beta indicator for Simulations Plus?
Simulations Plus (SLP) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.